Mirada Medical is a leading international brand in medical imaging. We develop advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care.
Mirada’s products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board and elsewhere. We specialize in simplifying technically complex image quantification allowing clinicians to confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. Our high value clinical software applications are used in prestigious cancer centers and hospitals worldwide.
Originally spun out of the University of Oxford, our team of dedicated engineers and world-renowned scientists is based in Oxford, England.
Mirada Medical and Nautilus Medical agree co-marketing of their technologies to solve PET/CT viewer portability.
The need for a portable PET/CT viewer is now solved with Mirada Medical and Nautilus joining technologies.
Presentation at Astro Reveals How Advanced Image Registration Helps Screen For Patients Requiring Adaptive Radiotherapy
Mirada Medical software applied to state-of-the-art Adaptive Radiotherapy (ART) is the subject of an oral presentation at the annual conference of the American Society of Radiation Oncology (ASTRO). The ASTRO conference is September 14-17 in San Francisco, California and is attended by leading radiation oncology professionals from around the world.
Mirada Medical signs research collaboration agreement with reflexion medical to further development of biologically-guided radiation therapy
Multi-modality cancer imaging specialists Mirada Medical (Oxford UK) have teamed up with an emerging developer of radiation therapy equipment for fighting cancer, RefleXion Medical (Burlingame, CA), to evaluate the performance of RefleXion’s novel PET-guided radiotherapy system.
Mirada Medical is introducing Registration AssuranceSM at the annual conference of the American Association of Physicists in Medicine (AAPM) to give clinicians total confidence in deformable registration as they integrate it into clinical practice.
Mirada Medical has won the 2014 British Venture Capital Association (BVCA) Management Team of the Year Award for the Midlands region. The black-tie award ceremony was held on the 18th of June in London and attended by leading private equity and venture capital professionals and the media.